Market Place
Sourcing Support
Novo nixes trial of blood pressure drug it bought in deal worth $1.3B
27 Jun 2024 //
BIOPHARMADIVE
Novo Nordisk to acquire ocedurenone for uncontrolled hypertension from KBP Bio
16 Oct 2023 //
GLOBENEWSWIRE
Ocedurenone (KBP-5074) Featured at ASN Kidney Week: Ocedurenone
06 Jan 2023 //
PR NEWSWIRE
KBP Biosciences Announces Update on KBP-5074 in Advanced Chronic Kidney Disease
16 Jun 2021 //
GLOBENEWSWIRE
Hope for chronic kidney disease as KBP Biosciences’ KBP-5074 shows promise
18 Dec 2020 //
CLINICALTRIALSARENA
KBP Biosciences Meets Primary Endpoint for BLOCK-CKD Phase 2b Study of KBP-5074
07 Dec 2020 //
GLOBENEWSWIRE
KBP Biosciences Announces Data Presentation at the American Society Nephrology
23 Oct 2020 //
GLOBENEWSWIRE
KBP Biosciences Doses Final Patient in BLOCK CKD Phase 2b Study of KBP-5074
05 Aug 2020 //
GLOBENEWSWIRE
KBP Biosciences Announces Peer-Reviewed Publication of Trial Design Manuscript
29 Jun 2020 //
GLOBENEWSWIRE
KBP Biosciences’ KBP-5074 Appears Well Tolerated in a single dose PK Study
21 May 2020 //
GLOBENEWSWIRE
KBP Biosciences Completes Enrollment of BLOCK CKD Phase 2b Study of KBP-5074
20 May 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.